COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #102
Source   PDF   Share   Tweet
See all 182 studies
Late treatment study
Saleemi et al., medRxiv, doi:10.1101/2020.08.05.20151027 (Preprint)
Time to negative PCR from symptom onset in COVID-19 patients on Hydroxych loroquine and Azithromycin - A real world experience
Retrospective 65 HC Q+AZ, 20 control patients, showing median time to negative PCR of 23 days for HC Q+AZ vs. 19 days for control. Confounding by indication. 100% of non-HC Q group had mild disease vs. 63% of the HC Q+AZ group. More comorbidities and symptoms in the HC Q+AZ group.
time to viral-, ↑21.0%, p<0.05, median time to PCR-
Source   PDF   Share   Tweet
See all 182 studies
Please send us corrections, updates, or comments.